| NRDS使用肺表面活性物质治疗后转归调查分析 |
| 投稿时间：2011-03-14 修订日期：2011-03-18 点此下载全文 |
| 引用本文：蔡成,吕勤,陈盛.NRDS使用肺表面活性物质治疗后转归调查分析[J].医学研究杂志,2012,41(1):112-114 |
| DOI：
|
| 摘要点击次数: 935 |
| 全文下载次数: 885 |
|
|
| 中文摘要:目的探讨肺表面活性物质（pulmonary surfactant，PS）治疗新生儿呼吸窘迫综合征（neonatal respiratory distress syndrome，NRDS）对患儿病情变化和转归结果的影响。方法对2007年6月~2009年6月笔者医院新生儿重症监护中心（neonatal intensive care unit，NICU）收治的43例NRDS患儿使用PS情况及转归结果进行统计调查分析，根据是否使用PS分为PS使用组和PS未用组，对两组患儿的一般临床情况、呼吸支持情况、症状变化及转归结果进行回顾性分析。结果调查发现NRDS患儿胎龄和出生体重均较低(分别为31.0±1.5周和1.734±0.170kg)；与PS未用组比较，PS使用组NRDS患儿支气管肺发育不良（bronchopulmonary dysplasia，BPD）的发生率差异无统计学意义，但脑室内出血（intraventricular hemorrhage，IVH）、早产儿视网膜病（retinopathy of prematurity，ROP）的发生率、病死率和住院时间均明显降低，呼吸窘迫或呼吸困难等症状消失的时间明显缩短，接受机械通气或NCPAP的时间明显减少。结论NRDS使用PS后虽不能完全改变转归和预后，但能有效地改善患儿肺顺应性及氧合功能，缩短需要机械通气及氧疗时间，提高患儿成活率，缩短住院时间。 |
| 中文关键词:肺表面活性物质 婴儿 新生 呼吸窘迫征 转归 |
| |
| Diagnosis and Investigation of Turnover of NRDS After Using Pulmonary Surfactant |
|
|
| Abstract:ObjectiveTo investigate the effects of using pulmonary surfactant to treat neonatal respiratory distress syndrome (NRDS) on the prognosis. MethodsTotally 43 infants of neonatal respiratory distress syndrome (NRDS) in NICU of our hospital from June 2007 to June 2009 were retrospectively analyzed. We analyzed the turnover of using pulmonary surfactant to treat NRDS. According to whether the using of PS, 43 infants of NRDS were divided into groups of using PS and groups of no using PS. We retrospectively analyzed their clinical cases, breath supporting cases, symptoms changes, prognosis. ResultsThe gestation age of NRDS was 31.0±1.5 weeks, birth weight 1.734±0.170kg.Compared with the gourp of no using PS, the incidence of bronchopulmonary dysplasia (BPD) was not statistically significant in gourp of using PS. But the incidence of intraventricular hemorrhage (IVH) and retinopathy of prematurity (ROP) was obviously reduced, the case fatality and length of stay were also obviously reduced, the syndrome of respiratory distress shortly disappeared, the time of mechanical ventilation or NCPAP were obviously reduced. ConclusionAfter using pulmonary surfactant, although the prognosis and turnover of NRDS were not completely altered, it can be effectively improve pulmonary compliance and oxygenation, and can reduce the time of mechanical ventilation and oxygen therapy, increase survival rate, reduce length of stay. |
| keywords:Pulmonary surfactant Infants Neonatal Respiratory distress syndrome Turnover |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
